BIO speaks on Capitol Hill about mpox preparedness

Mpox has proven to be a major public threat since its resurgence globally during the COVID years. On August 14, the World Health Organization (WHO) declared an international emergency as a highly virulent strain of mpox spreading from the Democratic Republic of the Congo.

As part of this dialogue, the Johns Hopkins Center for Health Security last week hosted an event, “Capitol Hill Steering Committee on Pandemic Preparedness and Health Security: The Current Mpox Crisis and Congress’s Role in Protecting the U.S. from Health Security Threats.”

Phyllis Arthur, executive vice president and head of healthcare policy and programs at the Biotechnology Innovation Organization (BIO), provided the industry perspective on addressing the current mpox crisis and lessons learned (or not) from the 2022 mpox outbreak.